Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD5 | Q86SK9 | 13/20 | 0.48 |
| ▸ | CYP2C8 | P10632 | 2/20 | 0.48 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | SCD | O00767 | 8/20 | 0.45 |
| ▸ | TAS2R8 | Q9NYW2 | 1/20 | 0.44 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4492919 | 0.90 | ALDH1A1 (0.51) | SCD5SCD | |
| SCHEMBL4506513 | 0.85 | SCD5 (0.49) | SCD5CYP2C8CYP2B6CYP2C9CYP2C19 | |
| SCHEMBL4499452 | 0.84 | SCD5 (0.43) | SCD5CYP2C8CYP2B6CYP2C9CYP2C19 | |
| SCHEMBL4516462 | 0.84 | GRM4 (0.47) | SCD5CYP2C9CYP2C19SCDTAS2R8 | |
| SCHEMBL4516523 | 0.80 | SCD (0.51) | SCD5CYP2C8CYP2B6SCD | |
| SCHEMBL4502765 | 0.79 | SCD5 (0.54) | SCD5SCD | |
| SCHEMBL4505284 | 0.79 | ALDH1A1 (0.66) | SCD5SCD | |
| SCHEMBL4515696 | 0.78 | ALDH1A1 (0.56) | SCD5SCD | |
| Hydrochloric Acid SCHEMBL4512405 | 0.78 | ALDH1A1 (0.56) | SCD5SCD | |
| SCHEMBL4507671 | 0.77 | SMN1; SMN2 (0.58) | SCD5CYP2C9CYP2C19SCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090325956-A1 | Aromatic amine derivative and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090325956-A1 | Aromatic amine derivative and use thereof | SCD, SCD5, SMS | SCD5 2/4885CYP2C8 419/4885CYP2B6 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.